ATDC member company Biofisica, an innovator in wound care therapy, has raised $2 million in venture debt financing from Leader Ventures. Biofisica plans to use the capital to continue funding its pioneering wound care product, POSiFECT. The product was launched in early 2007 and is now being marketed and sold in the United Kingdom. Biofisica has filed an application for 510(k) approval with the FDA to receive clearance to market its products in the United States.
“We are pleased that Leader Ventures has chosen to support our business model as we move forward with this important product in the field of wound care management,” said Rafael Andino, president and CEO of Biofisica. “This new infusion of capital supports our efforts to establish POSiFECT as a premier product in the wound care market and demonstrates Biofisica’s ability to attract high caliber investment partners.”